Didemnin Y
| Internal ID | 3058744e-e687-46ae-b3f9-25bd3bcca6f7 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | (4S)-4-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(3R)-3-hydroxydecanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-5-[(2S)-1-[(2S)-2-[[(2R)-1-[[(3S,6S,8S,12S,13S,16S,17S,20S,23S)-13-[(2S)-butan-2-yl]-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]amino]-4-methyl-1-oxopentan-2-yl]-methylcarbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]oxy-5-oxopentanoic acid |
| SMILES (Canonical) | CCCCCCCC(CC(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)OC(C)C(=O)N1CCCC1C(=O)N(C)C(CC(C)C)C(=O)NC2C(OC(=O)C(N(C(=O)C3CCCN3C(=O)C(NC(=O)C(C(=O)C(OC(=O)CC(C(NC2=O)C(C)CC)O)C(C)C)C)CC(C)C)C)CC4=CC=C(C=C4)OC)C)O |
| SMILES (Isomeric) | CCCCCCC[C@H](CC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N(C)[C@H](CC(C)C)C(=O)N[C@H]2[C@@H](OC(=O)[C@@H](N(C(=O)[C@@H]3CCCN3C(=O)[C@@H](NC(=O)[C@H](C(=O)[C@@H](OC(=O)C[C@@H]([C@@H](NC2=O)[C@@H](C)CC)O)C(C)C)C)CC(C)C)C)CC4=CC=C(C=C4)OC)C)O |
| InChI | InChI=1S/C87H138N14O26/c1-16-18-19-20-21-24-54(102)44-69(107)91-56(31-35-66(88)104)77(113)92-57(32-36-67(89)105)78(114)93-58(33-37-68(90)106)79(115)94-59(34-38-70(108)109)86(122)126-52(12)82(118)100-39-22-25-61(100)84(120)98(13)63(42-47(5)6)80(116)97-73-51(11)125-87(123)64(43-53-27-29-55(124-15)30-28-53)99(14)85(121)62-26-23-40-101(62)83(119)60(41-46(3)4)95-76(112)50(10)74(111)75(48(7)8)127-71(110)45-65(103)72(49(9)17-2)96-81(73)117/h27-30,46-52,54,56-65,72-73,75,102-103H,16-26,31-45H2,1-15H3,(H2,88,104)(H2,89,105)(H2,90,106)(H,91,107)(H,92,113)(H,93,114)(H,94,115)(H,95,112)(H,96,117)(H,97,116)(H,108,109)/t49-,50-,51-,52-,54+,56-,57-,58-,59-,60-,61-,62-,63+,64-,65-,72-,73-,75-/m0/s1 |
| InChI Key | GXKAOWYTJPGGBI-BHTIDRDUSA-N |
| Popularity | 3 references in papers |
| Molecular Formula | C87H138N14O26 |
| Molecular Weight | 1796.10 g/mol |
| Exact Mass | 1794.99067056 g/mol |
| Topological Polar Surface Area (TPSA) | 597.00 Ų |
| XlogP | 3.80 |
| Atomic LogP (AlogP) | 0.58 |
| H-Bond Acceptor | 25 |
| H-Bond Donor | 13 |
| Rotatable Bonds | 44 |
| CHEMBL510086 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.6445 | 64.45% |
| Caco-2 | - | 0.8590 | 85.90% |
| Blood Brain Barrier | - | 0.9750 | 97.50% |
| Human oral bioavailability | - | 0.6571 | 65.71% |
| Subcellular localzation | Lysosomes | 0.4867 | 48.67% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.7978 | 79.78% |
| OATP1B3 inhibitior | + | 0.9103 | 91.03% |
| MATE1 inhibitior | - | 0.8000 | 80.00% |
| OCT2 inhibitior | - | 0.9500 | 95.00% |
| BSEP inhibitior | + | 0.9569 | 95.69% |
| P-glycoprotein inhibitior | + | 0.7419 | 74.19% |
| P-glycoprotein substrate | + | 0.8774 | 87.74% |
| CYP3A4 substrate | + | 0.7644 | 76.44% |
| CYP2C9 substrate | - | 0.5962 | 59.62% |
| CYP2D6 substrate | - | 0.8305 | 83.05% |
| CYP3A4 inhibition | - | 0.7762 | 77.62% |
| CYP2C9 inhibition | - | 0.8907 | 89.07% |
| CYP2C19 inhibition | - | 0.8878 | 88.78% |
| CYP2D6 inhibition | - | 0.8860 | 88.60% |
| CYP1A2 inhibition | - | 0.9473 | 94.73% |
| CYP2C8 inhibition | + | 0.8486 | 84.86% |
| CYP inhibitory promiscuity | - | 0.9639 | 96.39% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | - | 0.8900 | 89.00% |
| Carcinogenicity (trinary) | Non-required | 0.6134 | 61.34% |
| Eye corrosion | - | 0.9885 | 98.85% |
| Eye irritation | - | 0.8953 | 89.53% |
| Skin irritation | - | 0.7752 | 77.52% |
| Skin corrosion | - | 0.9268 | 92.68% |
| Ames mutagenesis | - | 0.5748 | 57.48% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7289 | 72.89% |
| Micronuclear | + | 0.8600 | 86.00% |
| Hepatotoxicity | + | 0.5375 | 53.75% |
| skin sensitisation | - | 0.8800 | 88.00% |
| Respiratory toxicity | + | 0.7889 | 78.89% |
| Reproductive toxicity | + | 0.9667 | 96.67% |
| Mitochondrial toxicity | + | 0.9250 | 92.50% |
| Nephrotoxicity | - | 0.8914 | 89.14% |
| Acute Oral Toxicity (c) | III | 0.5961 | 59.61% |
| Estrogen receptor binding | - | 0.5220 | 52.20% |
| Androgen receptor binding | + | 0.7726 | 77.26% |
| Thyroid receptor binding | + | 0.7761 | 77.61% |
| Glucocorticoid receptor binding | + | 0.8159 | 81.59% |
| Aromatase binding | + | 0.8010 | 80.10% |
| PPAR gamma | + | 0.8007 | 80.07% |
| Honey bee toxicity | - | 0.6120 | 61.20% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | + | 0.5665 | 56.65% |
| Fish aquatic toxicity | + | 0.8718 | 87.18% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.99% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.93% | 96.61% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.83% | 96.09% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 98.98% | 99.17% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 98.75% | 93.00% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 97.93% | 90.17% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 97.01% | 94.66% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 96.80% | 82.38% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 96.36% | 93.56% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 96.30% | 95.56% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 95.93% | 91.19% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 95.64% | 97.09% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 95.58% | 91.11% |
| CHEMBL332 | P03956 | Matrix metalloproteinase-1 | 95.45% | 94.50% |
| CHEMBL261 | P00915 | Carbonic anhydrase I | 94.94% | 96.76% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 94.88% | 98.33% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 94.77% | 95.00% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 94.71% | 95.89% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 94.64% | 97.64% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 94.61% | 90.08% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 94.56% | 97.14% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 94.17% | 100.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 94.09% | 90.71% |
| CHEMBL4769 | O95749 | Geranylgeranyl pyrophosphate synthetase | 93.82% | 92.08% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 92.61% | 96.00% |
| CHEMBL4801 | P29466 | Caspase-1 | 92.50% | 96.85% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 91.70% | 97.29% |
| CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 91.60% | 97.86% |
| CHEMBL1902 | P62942 | FK506-binding protein 1A | 91.42% | 97.05% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 91.22% | 82.86% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 91.12% | 100.00% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 90.94% | 96.00% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 90.69% | 95.89% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 90.61% | 91.81% |
| CHEMBL205 | P00918 | Carbonic anhydrase II | 90.56% | 98.44% |
| CHEMBL1865 | Q9UBN7 | Histone deacetylase 6 | 90.06% | 97.03% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 88.48% | 94.45% |
| CHEMBL4330 | Q9NS75 | Cysteinyl leukotriene receptor 2 | 87.76% | 98.00% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 87.71% | 96.90% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 86.95% | 100.00% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 85.47% | 82.69% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 83.91% | 92.38% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 83.30% | 85.14% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 82.73% | 96.31% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 82.56% | 96.25% |
| CHEMBL2443 | P49862 | Kallikrein 7 | 82.50% | 94.00% |
| CHEMBL236 | P41143 | Delta opioid receptor | 82.49% | 99.35% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 82.47% | 99.18% |
| CHEMBL2535 | P11166 | Glucose transporter | 82.25% | 98.75% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 81.44% | 92.12% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 80.52% | 94.33% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 80.10% | 96.33% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 44592546 |
| LOTUS | LTS0228202 |
| wikiData | Q105023129 |